Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic-Pharmacodynamic Modeling Approaches

被引：45

作者：

Chaudhury, Anwesha ^{[1
]}

Zhu, Xu ^{[2
]}

Chu, Lulu ^{[3
]}

Goliaei, Ardeshir ^{[3
]}

June, Carl H. ^{[4
]}

Kearns, Jeffrey D. ^{[3
]}

Stein, Andrew M. ^{[1
]}

机构：

[1] Novartis Inst BioMed Res, Pharmacometr, 220 Massachusetts Ave, Cambridge, MA 02139 USA

[2] Novartis Inst BioMed Res, PK Sci Oncol, Cambridge, MA USA

[3] Novartis Inst BioMed Res, PK Sci Modeling & Simulat, Cambridge, MA USA

[4] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2020年 / 60卷

关键词：

cellular kinetic‐ pharmacodynamic model; chimeric antigen receptor‐ T cell (CAR‐ T cell) therapy; model‐ informed drug development (MIDD); quantitative systems pharmacology (QSP); MATHEMATICAL-MODEL; IMMUNOTHERAPY; STRATEGIES; RESPONSES; LEUKEMIA; AFFINITY; TUMORS;

D O I：

10.1002/jcph.1691

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Chimeric antigen receptor T cell (CAR-T cell) therapies have shown significant efficacy in CD19+ leukemias and lymphomas. There remain many challenges and questions for improving next-generation CAR-T cell therapies, and mathematical modeling of CAR-T cells may play a role in supporting further development. In this review, we introduce a mathematical modeling taxonomy for a set of relatively simple cellular kinetic-pharmacodynamic models that describe the in vivo dynamics of CAR-T cell and their interactions with cancer cells. We then discuss potential extensions of this model to include target binding, tumor distribution, cytokine-release syndrome, immunophenotype differentiation, and genotypic heterogeneity.

引用

页码：S147 / S159

页数：13

共 62 条

[41] Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia [J].

Mueller, Karen Thudium ;

Waldron, Edward ;

Grupp, Stephan A. ;

Levine, John E. ;

Laetsch, Theodore W. ;

Pulsipher, Michael A. ;

Boyer, Michael W. ;

August, Keith J. ;

Hamilton, Jason ;

Awasthi, Rakesh ;

Stein, Andrew M. ;

Sickert, Denise ;

Chakraborty, Abhijit ;

Levine, Bruce L. ;

June, Carl H. ;

Tomassian, Lori ;

Shah, Sweta S. ;

Leung, Mimi ;

Taran, Tetiana ;

Wood, Patricia A. ;

Maude, Shannon L. .

CLINICAL CANCER RESEARCH, 2018, 24 (24) :6175-6184

[42] Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia [J].

Mueller, Karen Thudium ;

Maude, Shannon L. ;

Porter, David L. ;

Frey, Noelle ;

Wood, Patricia ;

Han, Xia ;

Waldron, Edward ;

Chakraborty, Abhijit ;

Awasthi, Rakesh ;

Levine, Bruce L. ;

Melenhorst, J. Joseph ;

Grupp, Stephan A. ;

June, Carl H. ;

Lacey, Simon F. .

BLOOD, 2017, 130 (21) :2317-2325

[43] CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration [J].

Nobles, Christopher L. ;

Sherrill-Mix, Scott ;

Everett, John K. ;

Reddy, Shantan ;

Fraietta, Joseph A. ;

Porter, David L. ;

Frey, Noelle ;

Gill, Saar I. ;

Grupp, Stephan A. ;

Maude, Shannon L. ;

Siegel, Donald L. ;

Levine, Bruce L. ;

June, Carl H. ;

Lacey, Simon F. ;

Melenhorst, J. Joseph ;

Bushman, Frederic D. .

JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (02) :673-685

[44] Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells [J].

Norelli, Margherita ;

Camisa, Barbara ;

Barbiera, Giulia ;

Falcone, Laura ;

Purevdorj, Ayurzana ;

Genua, Marco ;

Sanvito, Francesca ;

Ponzoni, Maurilio ;

Doglioni, Claudio ;

Cristofori, Patrizia ;

Traversari, Catia ;

Bordignon, Claudio ;

Ciceri, Fabio ;

Ostuni, Renato ;

Bonini, Chiara ;

Casucci, Monica ;

Bondanza, Attilio .

NATURE MEDICINE, 2018, 24 (06) :739-+

[45] Stochastic Inheritance of Division and Death Times Determines the Size and Phenotype of CD8+ T Cell Families [J].

Pandit, Aridaman ;

De Boer, Rob J. .

FRONTIERS IN IMMUNOLOGY, 2019, 10

[46] A Flexible Approach for Context-Dependent Assessment of Quantitative Systems Pharmacology Models [J].

Ramanujan, Saroja ;

Chan, Jason R. ;

Friedrich, Christina M. ;

Thalhauser, Craig J. .

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (06) :340-343

[47]

Rowland M., 2005, CLIN PHARMACOKINET

[48] Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf [J].

Ruella, Marco ;

Kenderian, Saad S. .

BIODRUGS, 2017, 31 (06) :473-481

[49] The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma [J].

Ruella, Marco ;

Kenderian, Saad S. ;

Shestova, Olga ;

Fraietta, Joseph A. ;

Qayyum, Sohail ;

Zhang, Qian ;

Maus, Marcela V. ;

Liu, Xiaobin ;

Nunez-Cruz, Selene ;

Klichinsky, Michael ;

Kawalekar, Omkar U. ;

Milone, Michael ;

Lacey, Simon F. ;

Mato, Anthony ;

Schuster, Stephen J. ;

Kalos, Michael ;

June, Carl H. ;

Gill, Saar ;

Wasik, Mariusz A. .

CLINICAL CANCER RESEARCH, 2016, 22 (11) :2684-2696

[50] Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data [J].

Sahoo, Prativa ;

Yang, Xin ;

Abler, Daniel ;

Maestrini, Davide ;

Adhikarla, Vikram ;

Frankhouser, David ;

Cho, Heyrim ;

Machuca, Vanessa ;

Wang, Dongrui ;

Barish, Michael ;

Gutova, Margarita ;

Branciamore, Sergio ;

Brown, Christine E. ;

Rockne, Russell C. .

JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2020, 17 (162)

← 1 2 3 4 5 6 7 →